Center for Vaccine Research 2017

Center for Vaccine Research 2017

Center for Vaccine Research

Center for Vaccine Research consists of Department of Infectious Disease Immunology and Vaccine Development. The Center is unique in its composition as it includes not only a basic and translational research department but also GMP facilities, animal testing facilities and has expertise that enables accelerated development of new vaccines. 

Center for Vaccine Research

The program in CVR currently has two TB vaccines in late stage clinical testing and different liposomal adjuvant formulations and a novel Chlamydia trachomatis vaccine in phase 1 trials. In collaboration with industrial partners, CVR as developed novel TB diagnostic tests (the IGRA assays) that are in widespread worldwide clinical use today and has recently completed developing a novel specific skin test reagent (C-TB) to substitute for tuberculin. 

Research Consortia

POR TB Consortium

A dual function TB subunit vaccine

NeoPepVac

TransVac2

TBVAC2020

Eliciting lung-localized CD4 T cell responses against Mtb